This company listing is no longer active
Fiore Cannabis Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Belangrijke informatie
3.1%
Groei van de winst
40.5%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 23.1% |
| Inkomstengroei | 35.0% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -414.2% |
| Laatste winstupdate | 30 Jun 2022 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Fiore Cannabis geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 22 | 2 | -10 | 4 | 0 |
| 31 Mar 22 | 3 | -9 | 6 | 0 |
| 31 Dec 21 | 3 | -8 | 6 | 0 |
| 30 Sep 21 | 3 | -12 | 5 | 0 |
| 30 Jun 21 | 3 | -12 | 4 | 0 |
| 31 Mar 21 | 3 | -17 | 6 | 0 |
| 31 Dec 20 | 2 | -44 | 6 | 0 |
| 30 Sep 20 | 2 | -38 | 7 | 0 |
| 30 Jun 20 | 2 | -40 | 10 | 0 |
| 31 Mar 20 | 2 | -38 | 9 | 0 |
| 31 Dec 19 | 3 | -27 | 19 | 0 |
| 30 Sep 19 | 2 | -28 | 21 | 0 |
| 30 Jun 19 | 2 | -26 | 20 | 0 |
| 31 Mar 19 | 1 | -29 | 21 | 0 |
| 31 Dec 18 | 1 | -27 | 25 | 0 |
| 30 Sep 18 | 0 | -25 | 22 | 0 |
| 30 Jun 18 | 0 | -24 | 20 | 0 |
| 31 Mar 18 | 0 | -21 | 17 | 0 |
| 31 Dec 17 | 1 | -13 | 7 | 0 |
| 30 Sep 17 | 0 | -13 | 6 | 0 |
| 30 Jun 17 | 0 | -12 | 5 | 0 |
| 31 Mar 17 | 0 | -10 | 4 | 0 |
| 31 Dec 16 | 0 | -6 | 2 | 0 |
| 30 Sep 16 | 0 | -4 | 1 | 0 |
| 30 Jun 16 | 0 | -3 | 1 | 0 |
Kwaliteitswinsten: FIOR is currently unprofitable.
Groeiende winstmarge: FIOR is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: FIOR is unprofitable, but has reduced losses over the past 5 years at a rate of 3.1% per year.
Versnelling van de groei: Unable to compare FIOR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: FIOR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.8%).
Rendement op eigen vermogen
Hoge ROE: FIOR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.